<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37489358</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2035-8385</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>06</Day></PubDate></JournalIssue><Title>Neurology international</Title><ISOAbbreviation>Neurol Int</ISOAbbreviation></Journal><ArticleTitle>Long COVID, the Brain, Nerves, and Cognitive Function.</ArticleTitle><Pagination><StartPage>821</StartPage><EndPage>841</EndPage><MedlinePgn>821-841</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/neurolint15030052</ELocationID><Abstract><AbstractText>SARS-CoV-2, a single-stranded RNA coronavirus, causes an illness known as coronavirus disease 2019 (COVID-19). Long-term complications are an increasing issue in patients who have been infected with COVID-19 and may be a result of viral-associated systemic and central nervous system inflammation or may arise from a virus-induced hypercoagulable state. COVID-19 may incite changes in brain function with a wide range of lingering symptoms. Patients often experience fatigue and may note brain fog, sensorimotor symptoms, and sleep disturbances. Prolonged neurological and neuropsychiatric symptoms are prevalent and can interfere substantially in everyday life, leading to a massive public health concern. The mechanistic pathways by which SARS-CoV-2 infection causes neurological sequelae are an important subject of ongoing research. Inflammation- induced blood-brain barrier permeability or viral neuro-invasion and direct nerve damage may be involved. Though the mechanisms are uncertain, the resulting symptoms have been documented from numerous patient reports and studies. This review examines the constellation and spectrum of nervous system symptoms seen in long COVID and incorporates information on the prevalence of these symptoms, contributing factors, and typical course. Although treatment options are generally lacking, potential therapeutic approaches for alleviating symptoms and improving quality of life are explored.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reiss</LastName><ForeName>Allison B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Long Island, NY 11501, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greene</LastName><ForeName>Caitriona</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0003-7186-3508</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Long Island, NY 11501, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dayaramani</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Long Island, NY 11501, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rauchman</LastName><ForeName>Steven H</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0001-6297-1599</Identifier><AffiliationInfo><Affiliation>Fresno Institute of Neuroscience, Fresno, CA 93730, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stecker</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-9632-168X</Identifier><AffiliationInfo><Affiliation>Fresno Institute of Neuroscience, Fresno, CA 93730, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Leon</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Long Island, NY 11501, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinkhasov</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1148-902X</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Long Island, NY 11501, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Neurol Int</MedlineTA><NlmUniqueID>101551564</NlmUniqueID><ISSNLinking>2035-8385</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">long COVID syndrome</Keyword><Keyword MajorTopicYN="N">memory</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">neurologic sequelae</Keyword><Keyword MajorTopicYN="N">neuron</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37489358</ArticleId><ArticleId IdType="pmc">PMC10366776</ArticleId><ArticleId IdType="doi">10.3390/neurolint15030052</ArticleId><ArticleId IdType="pii">neurolint15030052</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ross Russell A.L., Hardwick M., Jeyanantham A., White L.M., Deb S., Burnside G., Joy H.M., Smith C.J., Pollak T.A., Nicholson T.R., et al. Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: A UK-wide cross-sectional surveillance study. Brain Commun. 2021;3:fcab168. doi: 10.1093/braincomms/fcab168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab168</ArticleId><ArticleId IdType="pmc">PMC8364668</ArticleId><ArticleId IdType="pubmed">34409289</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Benito Ballesteros A., Yeung S.P., Liu R., Saha A., Curtis L., Kaser M., Haggard M.P., Cheke L.G. COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study. Front. Aging Neurosci. 2022;14:804922. doi: 10.3389/fnagi.2022.804922.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804922</ArticleId><ArticleId IdType="pmc">PMC8968323</ArticleId><ArticleId IdType="pubmed">35370617</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J.X., Agbana Y.L., Sun Z.S., Fei S.W., Zhao H.Q., Zhou X.N., Chen J.H., Kassegne K. Increased interleukin-6 is associated with long COVID-19: A systematic review and meta-analysis. Infect. Dis. Poverty. 2023;12:43. doi: 10.1186/s40249-023-01086-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-023-01086-z</ArticleId><ArticleId IdType="pmc">PMC10123579</ArticleId><ArticleId IdType="pubmed">37095536</ArticleId></ArticleIdList></Reference><Reference><Citation>Shir D., Day G.S. Deciphering the contributions of neuroinflammation to neurodegeneration: Lessons from antibody-mediated encephalitis and coronavirus disease 2019. Curr. Opin. Neurol. 2022;35:212&#x2013;219. doi: 10.1097/WCO.0000000000001033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001033</ArticleId><ArticleId IdType="pmc">PMC8896289</ArticleId><ArticleId IdType="pubmed">35102125</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin A., Davison J., Tarrant R., Ross D., Halpin S., Simms A., Salman R., Sivan M. A Multidisciplinary NHS COVID-19 Service to Manage Post-COVID-19 Syndrome in the Community. J. Prim. Care Community Health. 2021;12:21501327211010994. doi: 10.1177/21501327211010994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211010994</ArticleId><ArticleId IdType="pmc">PMC8064663</ArticleId><ArticleId IdType="pubmed">33880955</ArticleId></ArticleIdList></Reference><Reference><Citation>Regunath H., Goldstein N.M., Guntur V.P. Long COVID: Where Are We in 2023? Mo. Med. 2023;120:102&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10121126</ArticleId><ArticleId IdType="pubmed">37091941</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J. Med. Virol. 2020;93:2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan L., Ahsan Z., Bint E Riaz H. An Unusual Case of Blackout in a COVID-19 Patient: COVID-19 Brain Fog. Cureus. 2023;15:e36273. doi: 10.7759/cureus.36273.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.36273</ArticleId><ArticleId IdType="pmc">PMC10105897</ArticleId><ArticleId IdType="pubmed">37073192</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., Malsy J., P&#xf6;ttgen J., Seddiq Zai S., Ufer F., Hadjilaou A., Schmiedel S., Addo M.M., Gerloff C., Heesen C., et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2:fcaa205. doi: 10.1093/braincomms/fcaa205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa205</ArticleId><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C., Giamberardino M.A., Martelletti P. Long COVID and especially headache syndromes. Curr. Opin. Neurol. 2023;36:168&#x2013;174. doi: 10.1097/WCO.0000000000001153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001153</ArticleId><ArticleId IdType="pubmed">37078648</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T., Workman C.D., Bryant A.D. Potential Factors That Contribute to Post-COVID-19 Fatigue in Women. Brain Sci. 2022;12:556. doi: 10.3390/brainsci12050556.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12050556</ArticleId><ArticleId IdType="pmc">PMC9139370</ArticleId><ArticleId IdType="pubmed">35624943</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe C. Front. Pharmacol. 2022;13:899198. doi: 10.3389/fphar.2022.899198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Busatto G.F., de Araujo A.L., Castaldelli-Maia J.M., Damiano R.F., Imamura M., Guedes B.F., de Rezende Pinna F., Sawamura M., Mancini M.C., da Silva K.R., et al. HCFMUSP Covid-19 Study Group. Post-acute sequelae of SARS-CoV-2 infection: Relationship of central nervous system manifestations with physical disability and systemic inflammation. Psychol. Med. 2022;52:2400. doi: 10.1017/S0033291722001799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291722001799</ArticleId><ArticleId IdType="pmc">PMC9981469</ArticleId><ArticleId IdType="pubmed">35757988</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa H.A., Shaw T.N., Knight S.B., Wemyss K., McClure F.A., Pearmain L., Prise I., Jagger C., Morgan D.J., Khan S., et al. Alterations in T and B cell function persist in convalescent COVID-19 patients. Med. 2021;2:720&#x2013;735. doi: 10.1016/j.medj.2021.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Haruwaka K., Ikegami A., Tachibana Y., Ohno N., Konishi H., Hashimoto A., Matsumoto M., Kato D., Ono R., Kiyama H., et al. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat. Commun. 2019;10:5816. doi: 10.1038/s41467-019-13812-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13812-z</ArticleId><ArticleId IdType="pmc">PMC6925219</ArticleId><ArticleId IdType="pubmed">31862977</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarlagadda A., Preston S.L., Jeyadhas R.P., Lang A.E., Hammamieh R., Clayton A.H. Blood-Brain Barrier: COVID-19, Pandemics, and Cytokine Norms. Innov. Clin. Neurosci. 2021;18:21&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8195557</ArticleId><ArticleId IdType="pubmed">34150359</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Hussain B., Chang J. Peripheral inflammation and blood-brain barrier disruption: Effects and mechanisms. CNS Neurosci. Ther. 2021;27:36&#x2013;47. doi: 10.1111/cns.13569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13569</ArticleId><ArticleId IdType="pmc">PMC7804893</ArticleId><ArticleId IdType="pubmed">33381913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Jin L., Zhang M., Wu Y., Duan Z., Guo Y., Wang C., Guo Y., Chen W., Liao Z., et al. Blood-brain barrier injury and neuroinflammation induced by SARS-CoV-2 in a lung-brain microphysiological system. Nat. Biomed. Eng. 2023. Advance online publication .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-023-01054-w</ArticleId><ArticleId IdType="pubmed">37349391</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung A.L., Vanderheiden A., Nordvig A.S., Sissoko C.A., Canoll P., Mariani M.B., Jiang X., Bricker T., Rosoklija G.B., Arango V., et al. COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain. 2022;145:4193&#x2013;4201. doi: 10.1093/brain/awac270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac270</ArticleId><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M., Sali&#xe9; H., Tanevski J., Killmer S., Lago M.S., Schlaak A.E., Mayer L., Matschke J., P&#xfc;schel K., Fitzek A., et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54:1594&#x2013;1610. doi: 10.1016/j.immuni.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Perl D.P., Steiner J., Pasternack N., Li W., Maric D., Safavi F., Horkayne-Szakaly I., Jones R., Stram M.N., et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain. 2022;145:2555&#x2013;2568. doi: 10.1093/brain/awac151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac151</ArticleId><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.H., Wood J., O&#x2019;Dea M.R., Dutton S., Shamardani K., Nwangwu K., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavi Y., Vojdani A., Halpert G., Sharif K., Ostrinski Y., Zyskind I., Lattin M.T., Zimmerman J., Silverberg J.I., Rosenberg A.Z., et al. Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients. Diagnostics. 2023;13:687. doi: 10.3390/diagnostics13040687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13040687</ArticleId><ArticleId IdType="pmc">PMC9955917</ArticleId><ArticleId IdType="pubmed">36832180</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C., Boesl F., Goereci Y., Gerhard A., Schweitzer F., Schroeder M., Foverskov-Rasmussen H., Heine J., Quitschau A., Kandil F.I., et al. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome. Brain Behav. Immun. 2023;109:139&#x2013;143. doi: 10.1016/j.bbi.2023.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.01.006</ArticleId><ArticleId IdType="pmc">PMC9841734</ArticleId><ArticleId IdType="pubmed">36657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer E.A., Kohn J.N., Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav. Immun. 2020;87:34&#x2013;39. doi: 10.1016/j.bbi.2020.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R.C., Huang K., Zhang H.P., Li L., Zhang Y.F., Tan C., Chen H.C., Jin M.L., Wang X.R. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J. Neuroinflamm. 2022;19:149. doi: 10.1186/s12974-022-02514-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02514-x</ArticleId><ArticleId IdType="pmc">PMC9198209</ArticleId><ArticleId IdType="pubmed">35705998</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T.P., DeOre B.J., Baldwin-Leclair A., Bullock T.A., McGary H.M., Khan J.A., Razmpour R., Hale J.F., Galie P.A., Potula R., et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol. Dis. 2020;146:105131. doi: 10.1016/j.nbd.2020.105131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta C.S., Torices S., da Rosa B.G., Marcos A.C., Alvarez-Rosa L., Siqueira M., Moreno-Rodriguez T., Matos A.D.R., Caetano B.C., Martins J.S.C.C., et al. Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-&#x3ba;B Non-Canonical Pathway and Mitochondrial Remodeling. Viruses. 2023;15:745. doi: 10.3390/v15030745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030745</ArticleId><ArticleId IdType="pmc">PMC10056985</ArticleId><ArticleId IdType="pubmed">36992454</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong G.U., Lyu J., Kim K.D., Chung Y.C., Yoon G.Y., Lee S., Hwang I., Shin W.H., Ko J., Lee J.Y., et al. SARS-CoV-2 infection of microglia elicits proinflammatory activation and apoptotic cell death. Microbiol. Spectr. 2022;10:e0109122. doi: 10.1128/spectrum.01091-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01091-22</ArticleId><ArticleId IdType="pmc">PMC9241873</ArticleId><ArticleId IdType="pubmed">35510852</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakshmana M.K. SARS-CoV-2-induced autophagy dysregulation may cause neuronal dysfunction in COVID-19. Neural Regen. Res. 2022;17:1255&#x2013;1256. doi: 10.4103/1673-5374.327333.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.327333</ArticleId><ArticleId IdType="pmc">PMC8643044</ArticleId><ArticleId IdType="pubmed">34782561</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondelli V., Pariante C.M. What can neuroimmunology teach us about the symptoms of long-COVID? Oxf. Open Immunol. 2021;2:iqab004. doi: 10.1093/oxfimm/iqab004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqab004</ArticleId><ArticleId IdType="pmc">PMC7928677</ArticleId><ArticleId IdType="pubmed">34192271</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., B&#xfc;ttiker P., Weissenberger S., Martin A., Ptacek R., Kream R.M. Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis. Med. Sci. Monit. 2021;27:e933015. doi: 10.12659/MSM.933015.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.933015</ArticleId><ArticleId IdType="pmc">PMC8120907</ArticleId><ArticleId IdType="pubmed">34016942</ArticleId></ArticleIdList></Reference><Reference><Citation>Welcome M.O., Mastorakis N.E. Neuropathophysiology of coronavirus disease 2019: Neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology. 2021;29:939&#x2013;963. doi: 10.1007/s10787-021-00806-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00806-x</ArticleId><ArticleId IdType="pmc">PMC8021940</ArticleId><ArticleId IdType="pubmed">33822324</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., R&#xf6;ssler A., Kimpel J., Kimpel J., Adolph T.E., Tilg H. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;163:495&#x2013;506. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L., Liu J., Zhu H., Lv Q., Liu R., Chen W., Tong W., Wei Q., et al. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct. Target Ther. 2021;6:337. doi: 10.1038/s41392-021-00719-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D., Singh E. An overview of the neurological aspects in COVID-19 infection. J. Chem. Neuroanat. 2022;122:102101. doi: 10.1016/j.jchemneu.2022.102101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2022.102101</ArticleId><ArticleId IdType="pmc">PMC9008979</ArticleId><ArticleId IdType="pubmed">35430271</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., Haferkamp U., Pfefferle S., Woo M.S., Heinrich F., Schweizer M., Appelt-Menzel A., Cubukova A., Barenberg J., Leu J., et al. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Rep. 2022;17:307&#x2013;1320. doi: 10.1016/j.stemcr.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Constant O., Barthelemy J., Bollor&#xe9; K., Tuaillon E., Gosselet F., Chable-Bessia C., Merida P., Muriaux D., Van de Perre P., Salinas S., et al. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier without Associated Deleterious Effects. Front. Immunol. 2021;12:697329. doi: 10.3389/fimmu.2021.697329.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.697329</ArticleId><ArticleId IdType="pmc">PMC8353323</ArticleId><ArticleId IdType="pubmed">34386007</ArticleId></ArticleIdList></Reference><Reference><Citation>Otifi H.M., Adiga B.K. Endothelial Dysfunction in Covid-19 Infection. Am. J. Med. Sci. 2022;363:281&#x2013;287. doi: 10.1016/j.amjms.2021.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2021.12.010</ArticleId><ArticleId IdType="pmc">PMC8802031</ArticleId><ArticleId IdType="pubmed">35093394</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson M.A., Rhea E.M., Knopp R.C., Banks W.A. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. Int. J. Mol. Sci. 2021;22:2681. doi: 10.3390/ijms22052681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052681</ArticleId><ArticleId IdType="pmc">PMC7961671</ArticleId><ArticleId IdType="pubmed">33800954</ArticleId></ArticleIdList></Reference><Reference><Citation>Salman M.A., Mallah S.I., Khalid W., Ryan Moran L., Abousedu Y.A.I., Jassim G.A. Characteristics of Patients with SARS-CoV-2 Positive Cerebrospinal Fluid: A Systematic Review. Int. J. Gen. Med. 2021;14:10385&#x2013;10395. doi: 10.2147/IJGM.S333966.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S333966</ArticleId><ArticleId IdType="pmc">PMC8721017</ArticleId><ArticleId IdType="pubmed">35002295</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xe4;ufer C., Schreiber C.S., Hartke A.S., Denden I., Stanelle-Bertram S., Beck S., Kouassi N.M., Beythien G., Becker K., Schreiner T., et al. Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine. 2022;79:103999. doi: 10.1016/j.ebiom.2022.103999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103999</ArticleId><ArticleId IdType="pmc">PMC9013202</ArticleId><ArticleId IdType="pubmed">35439679</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., et al. Neuropathology of patients with COVID-19 in Germany: A post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020;11:995&#x2013;998. doi: 10.1021/acschemneuro.0c00122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Bilinska K. SARS-CoV-2: Olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem. Neurosci. 2020;11:1200&#x2013;1203. doi: 10.1021/acschemneuro.0c00172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00172</ArticleId><ArticleId IdType="pubmed">32283006</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Br&#xfc;nink S., Greuel S., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuaid C., Brady M., Deane R. SARS-CoV-2: Is there neuroinvasion? Fluids Barriers CNS. 2021;18:32. doi: 10.1186/s12987-021-00267-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-021-00267-y</ArticleId><ArticleId IdType="pmc">PMC8278192</ArticleId><ArticleId IdType="pubmed">34261487</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka N., Shimada K., Ishii A., Kobayashi N., Kondo K. SARS-CoV-2 S1 protein causes brain inflammation by reducing intracerebral acetylcholine production. iScience. 2023;26:106954. doi: 10.1016/j.isci.2023.106954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.106954</ArticleId><ArticleId IdType="pmc">PMC10208654</ArticleId><ArticleId IdType="pubmed">37275532</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Simon N.M. Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19. JAMA Psychiatry. 2022;79:811&#x2013;817. doi: 10.1001/jamapsychiatry.2022.1616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.1616</ArticleId><ArticleId IdType="pubmed">35767287</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaut S. &#x201c;Long COVID-19&#x201d; and viral &#x201c;fibromyalgia-ness&#x201d;: Suggesting a mechanistic role for fascial myofibroblasts (Nineveh, the shadow is in the fascia) Front. Med. 2023;10:952278. doi: 10.3389/fmed.2023.952278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.952278</ArticleId><ArticleId IdType="pmc">PMC10117846</ArticleId><ArticleId IdType="pubmed">37089610</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A.M., Shoenfeld Y. Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants. Autoimmun. Rev. 2023;22:103230. doi: 10.1016/j.autrev.2022.103230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103230</ArticleId><ArticleId IdType="pubmed">36347462</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S., Nora-Krukle Z., Henning N., Eliassen E., Shikova E., Harrer T., Scheibenbogen C., Murovska M., Prusty B.K., European Network on ME/CFS (EUROMENE) Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2018;16:268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Barah F., Whiteside S., Batista S., Morris J. Neurological aspects of human parvovirus B19 infection: A systematic review. Rev. Med. Virol. 2014;24:154&#x2013;168. doi: 10.1002/rmv.1782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1782</ArticleId><ArticleId IdType="pmc">PMC4238837</ArticleId><ArticleId IdType="pubmed">24459081</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M., Paiva B., Montero-Mateo R., Garcia N., Zabaleta A. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome. Front. Immunol. 2021;12:656797. doi: 10.3389/fimmu.2021.656797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656797</ArticleId><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong K.H., Shapiro E.D., Soffer G.K. A Review of Post-treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist. Clin. Rev. Allergy Immunol. 2022;62:264&#x2013;271. doi: 10.1007/s12016-021-08906-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08906-w</ArticleId><ArticleId IdType="pubmed">34687445</ArticleId></ArticleIdList></Reference><Reference><Citation>Staud R. Are patients with systemic lupus erythematosus at increased risk for fibromyalgia? Curr. Rheumatol. Rep. 2006;8:430&#x2013;435. doi: 10.1007/s11926-006-0037-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-006-0037-z</ArticleId><ArticleId IdType="pubmed">17092442</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S.S., Duffield S.J., Goodson N.J. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract. Res. Clin. Rheumatol. 2019;33:101423. doi: 10.1016/j.berh.2019.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2019.06.005</ArticleId><ArticleId IdType="pubmed">31703796</ArticleId></ArticleIdList></Reference><Reference><Citation>Teodoro T., Edwards M.J., Isaacs J.D. A unifying theory for cognitive abnormalities in functional neurological disorders, fibromyalgia and chronic fatigue syndrome: Systematic review. J. Neurol. Neurosurg. Psychiatry. 2018;89:1308&#x2013;1319. doi: 10.1136/jnnp-2017-317823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317823</ArticleId><ArticleId IdType="pmc">PMC6288708</ArticleId><ArticleId IdType="pubmed">29735513</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M., Canoll P.D., Klein R.S. How COVID-19 Affects the Brain. JAMA Psychiatry. 2021;78:682&#x2013;683. doi: 10.1001/jamapsychiatry.2021.0500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaron L.A., Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann. Intern. Med. 2001;134:868&#x2013;881. doi: 10.7326/0003-4819-134-9_Part_2-200105011-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-134-9_Part_2-200105011-00011</ArticleId><ArticleId IdType="pubmed">11346323</ArticleId></ArticleIdList></Reference><Reference><Citation>Stecker M.M., Peltier M.R., Reiss A.B. The role of massive demographic databases in intractable illnesses: Denomics for dementia. AIMS Public Health. 2022;9:618&#x2013;629. doi: 10.3934/publichealth.2022043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/publichealth.2022043</ArticleId><ArticleId IdType="pmc">PMC9581740</ArticleId><ArticleId IdType="pubmed">36330282</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey Q., Sheikh A., Daines L., Vasileiou E. Symptoms and signs of long COVID: A rapid review and meta-analysis. J. Glob. Health. 2022;12:05014. doi: 10.7189/jogh.12.05014.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05014</ArticleId><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="pubmed">35596571</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucott J.N., Rebman A.W. Long-haul COVID: Heed the lessons from other infection-triggered illnesses. Lancet. 2021;397:967&#x2013;968. doi: 10.1016/S0140-6736(21)00446-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00446-3</ArticleId><ArticleId IdType="pmc">PMC7952095</ArticleId><ArticleId IdType="pubmed">33684352</ArticleId></ArticleIdList></Reference><Reference><Citation>El Sayed S., Shokry D., Gomaa S.M. Post-COVID-19 fatigue and anhedonia: A cross-sectional study and their correlation to post-recovery period. Neuropsychopharmacol. Rep. 2021;41:50&#x2013;55. doi: 10.1002/npr2.12154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/npr2.12154</ArticleId><ArticleId IdType="pmc">PMC8182964</ArticleId><ArticleId IdType="pubmed">33332756</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudgal S.K., Gaur R., Rulaniya S., Latha T., Agarwal R., Kumar S., Varshney S., Sharma S., Bhattacharya S., Kalyani V. Pooled Prevalence of Long COVID-19 Symptoms at 12 Months and Above Follow-Up Period: A Systematic Review and Meta-Analysis. Cureus. 2023;15:e36325. doi: 10.7759/cureus.36325.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.36325</ArticleId><ArticleId IdType="pmc">PMC10108372</ArticleId><ArticleId IdType="pubmed">37077615</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in adults at 6 months after COVID-19 infection. JAMA Network Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Verveen A., Wynberg E., van Willigen H.D.G., Boyd A., de Jong M.D., de Bree G., Davidovich U., Lok A., Moll van Charante E.P., Knoop H., et al. Severe Fatigue in the First Year Following SARS-CoV-2 Infection: A Prospective Cohort Study. Open Forum Infect. Dis. 2022;9:ofac127. doi: 10.1093/ofid/ofac127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac127</ArticleId><ArticleId IdType="pmc">PMC8995073</ArticleId><ArticleId IdType="pubmed">35415196</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M.I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C., et al. Neurological manifestations of long-COVID syndrome: A narrative review. Ther. Adv. Chronic Dis. 2022;13:20406223221076890. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Harenwall S., Heywood-Everett S., Henderson R., Godsell S., Jordan S., Moore A., Philpot U., Shepherd K., Smith J., Bland A.R. Post-Covid-19 Syndrome: Improvements in Health-Related Quality of Life Following Psychology-Led Interdisciplinary Virtual Rehabilitation. J. Prim. Care Community Health. 2021;12:21501319211067674. doi: 10.1177/21501319211067674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501319211067674</ArticleId><ArticleId IdType="pmc">PMC8721676</ArticleId><ArticleId IdType="pubmed">34939506</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolino D., Cesari M. Fatigue in the COVID-19 pandemic. Lancet Healthy Longev. 2022;3:e128&#x2013;e129. doi: 10.1016/S2666-7568(22)00029-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(22)00029-0</ArticleId><ArticleId IdType="pmc">PMC8901180</ArticleId><ArticleId IdType="pubmed">35282597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E., Rushforth A., Wieringa S., Taylor S., Rayner C., Husain L., Greenhalgh T. Persistent symptoms after COVID-19: Qualitative study of 114 &#x201c;long covid&#x201d; patients and draft quality principles for services. BMC Health Serv. Res. 2020;20:1144. doi: 10.1186/s12913-020-06001-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Ianosi B.A., Zamarian L., Beer R., Sahanic S., Lindner A., Kofler M., Schiefecker A.J., Mahlknecht P., Heim B., et al. Factors associated with impaired quality of life three months after being diagnosed with COVID-19. Qual. Life Res. 2022;31:1401&#x2013;1414. doi: 10.1007/s11136-021-02998-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02998-9</ArticleId><ArticleId IdType="pmc">PMC8476326</ArticleId><ArticleId IdType="pubmed">34580823</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L., Tosto-Mancuso J., Wood J., Cortes M., Kontorovich A., McCarthy D., Rizk D., Rozanski G., Breyman E., Nasr L., et al. Post-acute COVID-19 Syndrome Negatively Impacts Physical Function, Cognitive Function, Health-Related Quality of Life, and Participation. Am. J. Phys. Med. Rehabil. 2022;101:48&#x2013;52. doi: 10.1097/PHM.0000000000001910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos-Reed S.N., Weatherald J., Wrightson J.G. Chronic Fatigue and Postexertional Malaise in People Living With Long COVID: An Observational Study. Phys. Ther. 2022;102:pzac005. doi: 10.1093/ptj/pzac005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A Paradigm for Post-Covid-19 Fatigue Syndrome Analogous to ME/CFS. Front. Neurol. 2021;12:701419. doi: 10.3389/fneur.2021.701419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.701419</ArticleId><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T., Fietsam A.C., Deters J.R., Bryant A.D., Kamholz J. Post-covid-19 fatigue: Potential contributing factors. Brain Sci. 2020;10:1012. doi: 10.3390/brainsci10121012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10121012</ArticleId><ArticleId IdType="pmc">PMC7766297</ArticleId><ArticleId IdType="pubmed">33352638</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P., Ferrazzoli D., Sebastianelli L., Maestri R., Dezi S., Spampinato D., Saltuari L., Alibardi A., Engl M., Kofler M., et al. Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID-19. Eur. J. Neurol. 2022;29:1652&#x2013;1662. doi: 10.1111/ene.15278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15278</ArticleId><ArticleId IdType="pmc">PMC9111319</ArticleId><ArticleId IdType="pubmed">35138693</ArticleId></ArticleIdList></Reference><Reference><Citation>Versace V., Sebastianelli L., Ferrazzoli D., Romanello R., Ortelli P., Saltuari L., D&#x2019;Acunto A., Porrazzini F., Ajello V., Oliviero A., et al. Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19. Clin. Neurophysiol. 2021;132:1138&#x2013;1143. doi: 10.1016/j.clinph.2021.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.03.001</ArticleId><ArticleId IdType="pmc">PMC7954785</ArticleId><ArticleId IdType="pubmed">33774378</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadlier C., Albrich W.C., Neogi U., Lunjani N., Horgan M., O&#x2019;Toole P.W., O&#x2019;Mahony L. Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19. Allergy. 2022;77:1623&#x2013;1625. doi: 10.1111/all.15253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15253</ArticleId><ArticleId IdType="pmc">PMC9111264</ArticleId><ArticleId IdType="pubmed">35150456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ero&#x11f;lu &#x130;., Ero&#x11f;lu B.&#xc7;., G&#xfc;ven G.S. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19) Nutrition. 2021;90:111308. doi: 10.1016/j.nut.2021.111308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2021.111308</ArticleId><ArticleId IdType="pmc">PMC8087860</ArticleId><ArticleId IdType="pubmed">34111831</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabria M., Garc&#xed;a-S&#xe1;nchez C., Grunden N., Pons C., Arroyo J.A., G&#xf3;mez-Anson B., Est&#xe9;vez Garc&#xed;a M., Belv&#xed;s R., Moroll&#xf3;n N., Vera Igual J., et al. Post-COVID-19 fatigue: The contribution of cognitive and neuropsychiatric symptoms. J. Neurol. 2022;269:3990&#x2013;3999. doi: 10.1007/s00415-022-11141-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11141-8</ArticleId><ArticleId IdType="pmc">PMC9055007</ArticleId><ArticleId IdType="pubmed">35488918</ArticleId></ArticleIdList></Reference><Reference><Citation>Baslet G., Aybek S., Ducharme S., Modirrousta M., Nicholson T.R. Neuropsychiatry&#x2019;s Role in the Postacute Sequelae of COVID-19: Report From the American Neuropsychiatric Association Committee on Research. J. Neuropsychiatry Clin. Neurosci. 2022;34:341&#x2013;350. doi: 10.1176/appi.neuropsych.21080209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.21080209</ArticleId><ArticleId IdType="pubmed">35578802</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejb&#xf8;l E.K., Harbo T., Agergaard J., Madsen L.B., Pedersen T.H., &#xd8;stergaard L.J., Andersen H., Schr&#xf8;der H.D., Tankisi H. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology. Eur. J. Neurol. 2022;29:2832&#x2013;2841. doi: 10.1111/ene.15435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15435</ArticleId><ArticleId IdType="pmc">PMC9348124</ArticleId><ArticleId IdType="pubmed">35661354</ArticleId></ArticleIdList></Reference><Reference><Citation>Pires R.E., Reis I.G.N., Waldolato G.S., Pires D.D., Bidolegui F., Giordano V. What Do We Need to Know About Musculoskeletal Manifestations of COVID-19?: A Systematic Review. JBJS Rev. 2022;10:e22.00013. doi: 10.2106/JBJS.RVW.22.00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.RVW.22.00013</ArticleId><ArticleId IdType="pubmed">35658089</ArticleId></ArticleIdList></Reference><Reference><Citation>Khraisat B., Toubasi A., AlZoubi L., Al-Sayegh T., Mansour A. Meta-analysis of prevalence: The psychological sequelae among COVID-19 survivors. Int. J. Psychiatry Clin. Pract. 2021;26:234&#x2013;243. doi: 10.1080/13651501.2021.1993924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13651501.2021.1993924</ArticleId><ArticleId IdType="pubmed">34709105</ArticleId></ArticleIdList></Reference><Reference><Citation>Putri C., Arisa J., Hananto J.E., Hariyanto T.I., Kurniawan A. Psychiatric sequelae in COVID-19 survivors: A narrative review. World J. Psychiatry. 2021;11:821&#x2013;829. doi: 10.5498/wjp.v11.i10.821.</Citation><ArticleIdList><ArticleId IdType="doi">10.5498/wjp.v11.i10.821</ArticleId><ArticleId IdType="pmc">PMC8546765</ArticleId><ArticleId IdType="pubmed">34733644</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C., Stewart I.D., Plekhanova T., Cunningham P.S., Hazel A.L., Al-Sheklly B., Aul R., Bolton C.E., Chalder T., Chalmers J.D., et al. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: A prospective multicentre cohort study. Lancet Respir. Med. 2023. Advance online publication .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00124-8</ArticleId><ArticleId IdType="pmc">PMC10156429</ArticleId><ArticleId IdType="pubmed">37072018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakia H., Pradana K., Iskandar S. Risk factors for psychiatric symptoms in patients with long COVID: A systematic review. PLoS ONE. 2023;18:e0284075. doi: 10.1371/journal.pone.0284075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0284075</ArticleId><ArticleId IdType="pmc">PMC10081737</ArticleId><ArticleId IdType="pubmed">37027455</ArticleId></ArticleIdList></Reference><Reference><Citation>Gramaglia C., Gattoni E., Gambaro E., Bellan M., Balbo P.E., Baricich A., Sainaghi P.P., Pirisi M., Binda V., Feggi A., et al. Anxiety, Stress and Depression in COVID-19 Survivors from an Italian Cohort of Hospitalized Patients: Results from a 1-Year Follow-Up. Front. Psychiatry. 2022;13:862651. doi: 10.3389/fpsyt.2022.862651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.862651</ArticleId><ArticleId IdType="pmc">PMC9247238</ArticleId><ArticleId IdType="pubmed">35782424</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi H.Y., Alrashed A.M., Jawhari A.M., Abdel-Moneim A.S. Neuropsychiatric symptoms in post-COVID-19 long haulers. Acta Neuropsychiatr. 2022;34:318&#x2013;329. doi: 10.1017/neu.2022.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/neu.2022.13</ArticleId><ArticleId IdType="pubmed">35543105</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Beer R., Schiefecker A.J., Lindner A., Kofler M., Ianosi B.A., Mahlknecht P., Heim B., Peball M., Carbone F., et al. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study. Eur. J. Neurol. 2022;29:1685&#x2013;1696. doi: 10.1111/ene.15307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15307</ArticleId><ArticleId IdType="pmc">PMC9111823</ArticleId><ArticleId IdType="pubmed">35239247</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Lopes L., Silva R.O., de Sousa Lima G., de Ara&#xfa;jo Costa A.C., Barros D.F., Silva-N&#xe9;to R.P. Is there a common pathophysiological mechanism between COVID-19 and depression? Acta Neurol. Belg. 2021;121:1117&#x2013;1122. doi: 10.1007/s13760-021-01748-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-021-01748-5</ArticleId><ArticleId IdType="pmc">PMC8321009</ArticleId><ArticleId IdType="pubmed">34327666</ArticleId></ArticleIdList></Reference><Reference><Citation>Matits L., Munk M., Bizjak D.A., Kolassa I.T., Karrasch S., Vollrath S., Jerg A., Steinacker J.M. Inflammation and severity of depressive symptoms in physically active individuals after COVID-19&#x2014;An exploratory immunopsychological study investigating the effect of inflammation on depressive symptom severity. Brain Behav. Immun. Health. 2023;30:100614. doi: 10.1016/j.bbih.2023.100614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100614</ArticleId><ArticleId IdType="pmc">PMC10035808</ArticleId><ArticleId IdType="pubmed">37033771</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S., Karim M., Gupta V., Goel H., Jain R. A Comprehensive Review of COVID-19-Associated Endocrine Manifestations. South. Med. J. 2023;116:350&#x2013;354. doi: 10.14423/SMJ.0000000000001542.</Citation><ArticleIdList><ArticleId IdType="doi">10.14423/SMJ.0000000000001542</ArticleId><ArticleId IdType="pmc">PMC10044587</ArticleId><ArticleId IdType="pubmed">37011583</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H.T., Jubran A.S., Almulla A.F., Moustafa S.R., Maes M. Increased insulin resistance due to Long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection. Braz. J. Psychiatry. 2023 doi: 10.47626/1516-4446-2022-3002. Advance online publication .</Citation><ArticleIdList><ArticleId IdType="doi">10.47626/1516-4446-2022-3002</ArticleId><ArticleId IdType="pmc">PMC10288478</ArticleId><ArticleId IdType="pubmed">36917827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonati M., Campi R., Segre G. Psychological impact of the quarantine during the COVID-19 pandemic on the general European adult population: A systematic review of the evidence. Epidemiol. Psychiatr. Sci. 2022;31:e27. doi: 10.1017/S2045796022000051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S2045796022000051</ArticleId><ArticleId IdType="pmc">PMC9069583</ArticleId><ArticleId IdType="pubmed">35475479</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos E.R.R., Silva de Paula J.L., Tardieux F.M., Costa-E-Silva V.N., Lal A., Leite A.F.B. Association between COVID-19 and anxiety during social isolation: A systematic review. World J. Clin. Cases. 2021;9:7433&#x2013;7444. doi: 10.12998/wjcc.v9.i25.7433.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v9.i25.7433</ArticleId><ArticleId IdType="pmc">PMC8464456</ArticleId><ArticleId IdType="pubmed">34616809</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrabissa G., Simpson S.G. Psychological Consequences of Social Isolation During COVID-19 Outbreak. Front. Psychol. 2020;11:2201. doi: 10.3389/fpsyg.2020.02201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2020.02201</ArticleId><ArticleId IdType="pmc">PMC7513674</ArticleId><ArticleId IdType="pubmed">33013572</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid&#x2014;Mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed G.K., Khedr E.M., Hamad D.A., Meshref T.S., Hashem M.M., Aly M.M. Long term impact of Covid-19 infection on sleep and mental health: A cross-sectional study. Psychiatry Res. 2021;305:114243. doi: 10.1016/j.psychres.2021.114243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2021.114243</ArticleId><ArticleId IdType="pmc">PMC8507572</ArticleId><ArticleId IdType="pubmed">34673325</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A., Bodicherla K.P., Bashir A., Batchelder E., Jolly T.S. COVID-19 and Obsessive-Compulsive Disorder: The Nightmare Just Got Real. Prim. Care Companion CNS Disord. 2021;23:20l02877. doi: 10.4088/PCC.20l02877.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/PCC.20l02877</ArticleId><ArticleId IdType="pubmed">34000177</ArticleId></ArticleIdList></Reference><Reference><Citation>Loosen A.M., Skvortsova V., Hauser T.U. Obsessive-compulsive symptoms and information seeking during the Covid-19 pandemic. Transl. Psychiatry. 2021;11:309. doi: 10.1038/s41398-021-01410-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01410-x</ArticleId><ArticleId IdType="pmc">PMC8138954</ArticleId><ArticleId IdType="pubmed">34021112</ArticleId></ArticleIdList></Reference><Reference><Citation>Abba-Aji A., Li D., Hrabok M., Shalaby R., Gusnowski A., Vuong W., Surood S., Nkire N., Li X.M., Greenshaw A.J., et al. COVID-19 pandemic and mental health: Prevalence and correlates of new-onset obsessive-compulsive symptoms in a Canadian Province. Int. J. Environ. Res. Public Health. 2020;17:6986. doi: 10.3390/ijerph17196986.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17196986</ArticleId><ArticleId IdType="pmc">PMC7579625</ArticleId><ArticleId IdType="pubmed">32987764</ArticleId></ArticleIdList></Reference><Reference><Citation>Linde E.S., Varga T.V., Clotworthy A. Obsessive-Compulsive Disorder During the COVID-19 Pandemic-A Systematic Review. Front. Psychiatry. 2022;13:806872. doi: 10.3389/fpsyt.2022.806872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.806872</ArticleId><ArticleId IdType="pmc">PMC8989845</ArticleId><ArticleId IdType="pubmed">35401266</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaseda E.T., Levine A.J. Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. Clin. Neuropsychol. 2020;34:1498&#x2013;1514. doi: 10.1080/13854046.2020.1811894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2020.1811894</ArticleId><ArticleId IdType="pubmed">32847484</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., De Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I., Melloni E.M.T., Furlan R., Ciceri F., Rovere-Querini P., et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao J., Wang C., Teng C., Wang M., Zhou S., Zhao K., Ye X., Wang Y. Prevalence and Associated Factors of PTSD Symptoms After the COVID-19 Epidemic Outbreak in an Online Survey in China: The Age and Gender Differences Matter. Neuropsychiatr. Dis. Treat. 2022;18:761&#x2013;771. doi: 10.2147/NDT.S351042.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S351042</ArticleId><ArticleId IdType="pmc">PMC8994999</ArticleId><ArticleId IdType="pubmed">35414744</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene T., El-Leithy S., Billings J., Albert I., Birch J., Campbell M., Ehntholt K., Fortune L., Gilbert N., Grey N., et al. Anticipating PTSD in severe COVID survivors: The case for screen-and-treat. Eur. J. Psychotraumatol. 2022;13:1959707. doi: 10.1080/20008198.2021.1959707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20008198.2021.1959707</ArticleId><ArticleId IdType="pmc">PMC8797726</ArticleId><ArticleId IdType="pubmed">35096282</ArticleId></ArticleIdList></Reference><Reference><Citation>Houben-Wilke S., Go&#xeb;rtz Y.M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V., van Herck M., Burtin C., Posthuma R., Franssen F.M., et al. The Impact of Long COVID-19 on Mental Health: Observational 6-Month Follow-Up Study. JMIR Ment. Health. 2022;9:e33704. doi: 10.2196/33704.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/33704</ArticleId><ArticleId IdType="pmc">PMC8914795</ArticleId><ArticleId IdType="pubmed">35200155</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarraj J.P.J., Burkett A.B., Hinds S.N., Paz A.S., Assing A., Juneja S., Colpo G.D., Torres L.F., Cho S.M., Gusdon A.M., et al. Pain and Other Neurological Symptoms Are Present at 3 Months After Hospitalization in COVID-19 Patients. Front. Pain Res. 2021;2:737961. doi: 10.3389/fpain.2021.737961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpain.2021.737961</ArticleId><ArticleId IdType="pmc">PMC8915679</ArticleId><ArticleId IdType="pubmed">35295410</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou T.M., Joca S., Wegener G., Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19&#x2014;A systematic review. Brain Behav. Immun. 2021;97:328&#x2013;348. doi: 10.1016/j.bbi.2021.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando S.J., Klepacz L., Lynch S., Tavakkoli M., Dornbush R., Baharani R., Smolin Y., Bartell A. COVID-19 Psychosis: A Potential New Neuropsychiatric Condition Triggered by Novel Coronavirus Infection and the Inflammatory Response? Psychosomatics. 2020;61:551&#x2013;555. doi: 10.1016/j.psym.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psym.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7236749</ArticleId><ArticleId IdType="pubmed">32593479</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary A.M.D., Musavi N.B., Saboor S., Javed S., Khan S., Naveed S. Psychosis during the COVID-19 pandemic: A systematic review of case reports and case series. J. Psychiatr. Res. 2022;153:37&#x2013;55. doi: 10.1016/j.jpsychires.2022.06.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.06.041</ArticleId><ArticleId IdType="pmc">PMC9248300</ArticleId><ArticleId IdType="pubmed">35797814</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith C.M., Gilbert E.B., Riordan P.A., Helmke N., von Isenburg M., Kincaid B.R., Shirey K.G. Covid-19-associated psychosis: A systematic review of case reports. Gen. Hosp. Psychiatry. 2021;73:84&#x2013;100. doi: 10.1016/j.genhosppsych.2021.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2021.10.003</ArticleId><ArticleId IdType="pmc">PMC8546431</ArticleId><ArticleId IdType="pubmed">34717240</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hanlon S., Inouye S.K. Delirium: A missing piece in the COVID-19 pandemic puzzle. Age Ageing. 2020;49:497&#x2013;498. doi: 10.1093/ageing/afaa094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afaa094</ArticleId><ArticleId IdType="pmc">PMC7239228</ArticleId><ArticleId IdType="pubmed">32374367</ArticleId></ArticleIdList></Reference><Reference><Citation>Otani K., Fukushima H., Matsuishi K. COVID-19 delirium and encephalopathy: Pathophysiology assumed in the first 3 years of the ongoing pandemic. Brain Disord. 2023;10:100074. doi: 10.1016/j.dscb.2023.100074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dscb.2023.100074</ArticleId><ArticleId IdType="pmc">PMC10076074</ArticleId><ArticleId IdType="pubmed">37056914</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebora P., Rozzini R., Bianchetti A., Blangiardo P., Marchegiani A., Piazzoli A., Mazzeo F., Cesaroni G., Chizzoli A., Guerini F., et al. Delirium in patients with SARS-CoV-2 infection: A multicenter study. J. Am. Geriatr. Soc. 2020;69:293&#x2013;299. doi: 10.1111/jgs.16969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16969</ArticleId><ArticleId IdType="pmc">PMC7753490</ArticleId><ArticleId IdType="pubmed">33411332</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., Cho S.M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V., Stefanou M.-I., Demetriou M., Siafakas N., Makris M., Tsivgoulis G., Zoumpourlis V., Kympouropoulos S., Tsoporis J., Spandidos D., et al. Long Covid and neuropsychiatric manifestations (review) Exp. Ther. Med. 2022;23:363. doi: 10.3892/etm.2022.11290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpelli S., Nadorff M.R., Bjorvatn B., Chung F., Dauvilliers Y., Espie C.A., Inoue Y., Matsui K., Merikanto I., Morin C.M., et al. Nightmares in People with COVID-19: Did Coronavirus Infect Our Dreams? Nat. Sci. Sleep. 2022;14:93&#x2013;108. doi: 10.2147/NSS.S344299.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NSS.S344299</ArticleId><ArticleId IdType="pmc">PMC8800372</ArticleId><ArticleId IdType="pubmed">35115852</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Mills A.J., Kelley M., Toran L.S., Smith B., Dalakas M.C., Nath A. Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID. Neuroimmunol. Neuroinflamm. 2022;9:e1146. doi: 10.1212/NXI.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Hern&#xe1;ndez L., Cabal-Paz B., Mayo-Canalejo D., Horga A. Post-COVID symptoms of potential peripheral nervous and muscular origin. Neurol. Perspect. 2021;1:S25&#x2013;S30. doi: 10.1016/j.neurop.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurop.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8669717</ArticleId><ArticleId IdType="pubmed">38620983</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Bobkova P., Spiridonova E., Shikhaleva A., Gamirova A., Blyuss O., Nekliudov N., Bugaeva P., Andreeva M., DunnGalvin A., et al. Sechenov StopCOVID Research Team Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin. Exp. Allergy. 2021;51:1107&#x2013;1120. doi: 10.1111/cea.13997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahlgren C., Forsberg G., Divanoglou A., &#xd6;stholm Balkhed &#xc5;., Niward K., Berg S., Levi R. Two-year follow-up of patients with post-COVID-19 condition in Sweden: A prospective cohort study. Lancet Reg. Health Eur. 2023 doi: 10.1016/j.lanepe.2023.100595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100595</ArticleId><ArticleId IdType="pmc">PMC9951394</ArticleId><ArticleId IdType="pubmed">36855599</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Cristillo V., Cotti Piccinelli S., Zoppi N., Bonzi G., Sattin D., Schiavolin S., Raggi A., Canale A., Gipponi S., et al. Long-term neurological manifestations of COVID-19: Prevalence and predictive factors. Neurol. Sci. 2021;42:4903&#x2013;4907. doi: 10.1007/s10072-021-05586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05586-4</ArticleId><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stefano G., Falco P., Galosi E., Di Pietro G., Leone C., Truini A. A systematic review and metanalysis of neuropathic pain associated with coronavirus disease 2019. Eur. J. Pain. 2023;27:44&#x2013;53. doi: 10.1002/ejp.2055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.2055</ArticleId><ArticleId IdType="pmc">PMC9877974</ArticleId><ArticleId IdType="pubmed">36367322</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Nijs J., Neblett R., Polli A., Moens M., Goudman L., Shekhar Patil M., Knaggs R.D., Pickering G., Arendt-Nielsen L. Phenotyping Post-COVID Pain as a Nociceptive, Neuropathic, or Nociplastic Pain Condition. Biomedicines. 2022;10:2562. doi: 10.3390/biomedicines10102562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10102562</ArticleId><ArticleId IdType="pmc">PMC9599440</ArticleId><ArticleId IdType="pubmed">36289827</ArticleId></ArticleIdList></Reference><Reference><Citation>Burakgazi A.Z. Small-Fiber Neuropathy Possibly Associated with COVID-19. Case Rep. Neurol. 2022;14:208&#x2013;212. doi: 10.1159/000524205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000524205</ArticleId><ArticleId IdType="pmc">PMC9149535</ArticleId><ArticleId IdType="pubmed">35702058</ArticleId></ArticleIdList></Reference><Reference><Citation>Odozor C.U., Kannampallil T., Ben Abdallah A., Roles K., Burk C., Warner B.C., Alaverdyan H., Clifford D.B., Piccirillo J.F., Haroutounian S. Post-acute sensory neurological sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: The COVID-PN observational cohort study. Pain. 2022;163:2398&#x2013;2410. doi: 10.1097/j.pain.0000000000002639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002639</ArticleId><ArticleId IdType="pubmed">35324536</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieco T., Gomes V., Rossi A., Cantisani C., Greco M.E., Rossi G., Sernicola A., Pellacani G. The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series. J. Clin. Med. 2022;11:4474. doi: 10.3390/jcm11154474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154474</ArticleId><ArticleId IdType="pmc">PMC9369885</ArticleId><ArticleId IdType="pubmed">35956094</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinduja A., Moutairou A., Calvet J.H. Sudomotor dysfunction in patients recovered from COVID-19. Neurophysiol. Clin. 2021;51:193&#x2013;196. doi: 10.1016/j.neucli.2021.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2021.01.003</ArticleId><ArticleId IdType="pmc">PMC7835104</ArticleId><ArticleId IdType="pubmed">33551341</ArticleId></ArticleIdList></Reference><Reference><Citation>Zis P., Ioannou C., Artemiadis A., Christodoulou K., Kalampokini S., Hadjigeorgiou G.M. Prevalence and Determinants of Chronic Pain Post-COVID: Cross-Sectional Study. J. Clin. Med. 2022;11:5569. doi: 10.3390/jcm11195569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11195569</ArticleId><ArticleId IdType="pmc">PMC9573502</ArticleId><ArticleId IdType="pubmed">36233443</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams R.M.C., Simpson D.M., Navis A., Jette N., Zhou L., Shin S.C. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. 2022;65:440&#x2013;443. doi: 10.1002/mus.27458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27458</ArticleId><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinzon R.T., Wijaya V.O., Jody A.A., Nunsio P.N., Buana R.B. Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis. J. Infect. Public Health. 2022;15:856&#x2013;869. doi: 10.1016/j.jiph.2022.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.06.013</ArticleId><ArticleId IdType="pmc">PMC9221935</ArticleId><ArticleId IdType="pubmed">35785594</ArticleId></ArticleIdList></Reference><Reference><Citation>Irisson-Mora I., Salgado-Cordero A.M., Reyes-Var&#xf3;n E., Cataneo-Pi&#xf1;a D.J., Fern&#xe1;ndez-S&#xe1;nchez M., Buend&#xed;a-Rold&#xe1;n I., Salazar-Lezama M.A., Occupational Health and Preventive Medicine Consortium Comparison between the persistence of post COVID-19 symptoms on critical patients requiring invasive mechanical ventilation and non-critical patients. PLoS ONE. 2022;17:e0273041. doi: 10.1371/journal.pone.0273041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0273041</ArticleId><ArticleId IdType="pmc">PMC9394845</ArticleId><ArticleId IdType="pubmed">35994441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ser M.H., &#xc7;al&#x131;ku&#x15f;u F.Z., Tanr&#x131;verdi U., Abbaszade H., Hakyemez S., Balkan &#x130;.&#x130;., Karaali R., G&#xfc;nd&#xfc;z A. Autonomic and neuropathic complaints of long-COVID objectified: An investigation from electrophysiological perspective. Neurol. Sci. 2022;43:6167&#x2013;6177. doi: 10.1007/s10072-022-06350-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06350-y</ArticleId><ArticleId IdType="pmc">PMC9395948</ArticleId><ArticleId IdType="pubmed">35994135</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E., Newcombe V., Michell A., Thornton R., Grainger A., Anwar F., Warburton E., Menon D., Trivedi M., Sawcer S. Mononeuritis multiplex: An unexpectedly common feature of severe COVID-19. J. Neurol. 2021;268:2685&#x2013;2689. doi: 10.1007/s00415-020-10321-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10321-8</ArticleId><ArticleId IdType="pmc">PMC7690651</ArticleId><ArticleId IdType="pubmed">33244712</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmood S.B.Z., Mushtaq M.Z., Kanwar D., Ali S.A. Lower limb axonal mononeuropathies as sequelae of COVID-19: A case report and review of literature. Egypt. J. Neurol. Psychiatr. Neurosurg. 2022;58:22. doi: 10.1186/s41983-022-00458-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41983-022-00458-w</ArticleId><ArticleId IdType="pmc">PMC8853404</ArticleId><ArticleId IdType="pubmed">35194370</ArticleId></ArticleIdList></Reference><Reference><Citation>Carberry N., Badu H., Ulane C.M., Beckley A., Rosenberg S.J., Brenner K., Brannagan T.H. Mononeuropathy Multiplex After COVID-19. J. Clin. Neuromuscul. Dis. 2021;23:24&#x2013;30. doi: 10.1097/CND.0000000000000367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CND.0000000000000367</ArticleId><ArticleId IdType="pubmed">34431798</ArticleId></ArticleIdList></Reference><Reference><Citation>Law S.M., Scott K., Alkarn A., Mahjoub A., Mallik A.K., Roditi G., Choo-Kang B. COVID-19 associated phrenic nerve mononeuritis: A case series. Thorax. 2022;77:834&#x2013;838. doi: 10.1136/thoraxjnl-2021-218257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-218257</ArticleId><ArticleId IdType="pubmed">35459747</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimou L., Stefanou M.I., Katsanos A.H., Fragkou P.C., Papadopoulou M., Moschovos C., Michopoulos I., Kokotis P., Bakirtzis C., Naska A., et al. Prevalence, clinical characteristics and outcomes of Guillain-Barr&#xe9; syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur. J. Neurol. 2021;28:3517&#x2013;3529. doi: 10.1111/ene.14860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14860</ArticleId><ArticleId IdType="pmc">PMC8250909</ArticleId><ArticleId IdType="pubmed">33837630</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaqoob A., Dar W., Khuja Z., Bukhari I., Raina A., Ganie H., Chandra A., Wani M., Asimi R., Wani F. Miller Fisher syndrome associated with COVID 19. J. Family Med. Prim. Care. 2022;11:4023&#x2013;4025. doi: 10.4103/jfmpc.jfmpc_1864_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_1864_21</ArticleId><ArticleId IdType="pmc">PMC9648327</ArticleId><ArticleId IdType="pubmed">36387653</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekpour M., Khanmohammadi S., Meybodi M.J.E., Shekouh D., Rahmanian M.R., Kardeh S., Azarpira N. COVID-19 as a trigger of Guillain-Barr&#xe9; syndrome: A review of the molecular mechanism. Immun. Inflamm. Dis. 2023;11:e875. doi: 10.1002/iid3.875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.875</ArticleId><ArticleId IdType="pmc">PMC10187022</ArticleId><ArticleId IdType="pubmed">37249286</ArticleId></ArticleIdList></Reference><Reference><Citation>Noon A., Malhi J.K., Wong C.K. Atypical Guillain-Barr&#xe9; Syndrome Presenting After COVID-19 Infection. Cureus. 2022;14:e29521. doi: 10.7759/cureus.29521.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.29521</ArticleId><ArticleId IdType="pmc">PMC9589521</ArticleId><ArticleId IdType="pubmed">36312645</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J., Scorza F.A., Scorza C.A., Fiorini A.C. Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the Intensive Care Unit. Arq. Neuropsiquiatr. 2021;79:924&#x2013;928. doi: 10.1590/0004-282x-anp-2021-0030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282x-anp-2021-0030</ArticleId><ArticleId IdType="pubmed">34287509</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Treister R., Lang M., Oaklander A.L. IVIg for apparently autoimmune small-fiber polyneuropathy: First analysis of efficacy and safety. Ther. Adv. Neurol. Disord. 2018;11:1756285617744484. doi: 10.1177/1756285617744484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756285617744484</ArticleId><ArticleId IdType="pmc">PMC5791555</ArticleId><ArticleId IdType="pubmed">29403541</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C., Berlit P., Pr&#xfc;ss H. Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology. Neurol. Res. Pract. 2022;4:28. doi: 10.1186/s42466-022-00191-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-022-00191-y</ArticleId><ArticleId IdType="pmc">PMC9288923</ArticleId><ArticleId IdType="pubmed">35843984</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A., Ruiz-Ruig&#xf3;mez M., Laguna-Goya R., Arrieta-Ortubay E., Chivite-Lacaba M., Gonz&#xe1;lez-Cuadrado C., Lalueza A., Almendro-Vazquez P., Serrano A., Aguado J.M., et al. A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID. Biomedicines. 2021;9:1540. doi: 10.3390/biomedicines9111540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9111540</ArticleId><ArticleId IdType="pmc">PMC8614904</ArticleId><ArticleId IdType="pubmed">34829769</ArticleId></ArticleIdList></Reference><Reference><Citation>McWilliam M., Samuel M., Alkufri F.H. Neuropathic pain post-COVID-19: A case report. BMJ Case Rep. 2021;14:e243459. doi: 10.1136/bcr-2021-243459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-243459</ArticleId><ArticleId IdType="pmc">PMC8728379</ArticleId><ArticleId IdType="pubmed">34301704</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson J.S., Thornton A.C., Ainger T., Garvy B.A. Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms. Front. Immunol. 2023;13:1033651. doi: 10.3389/fimmu.2022.1033651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1033651</ArticleId><ArticleId IdType="pmc">PMC9932260</ArticleId><ArticleId IdType="pubmed">36818469</ArticleId></ArticleIdList></Reference><Reference><Citation>Attal N., Martinez V., Bouhassira D. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep. 2021;6:e884. doi: 10.1097/PR9.0000000000000884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000884</ArticleId><ArticleId IdType="pmc">PMC7850724</ArticleId><ArticleId IdType="pubmed">33537521</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Tallawy S.N., Perglozzi J.V., Ahmed R.S., Kaki A.M., Nagiub M.S., LeQuang J.K., Hadarah M.M. Pain Management in the Post-COVID Era-An Update: A Narrative Review. Pain Ther. 2023;12:423&#x2013;448. doi: 10.1007/s40122-023-00486-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40122-023-00486-1</ArticleId><ArticleId IdType="pmc">PMC9971680</ArticleId><ArticleId IdType="pubmed">36853484</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xf3;rdova-Mart&#xed;nez A., Caballero-Garc&#xed;a A., P&#xe9;rez-Valdecantos D., Roche E., Noriega-Gonz&#xe1;lez D.C. Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment. Biomedicines. 2022;10:1051. doi: 10.3390/biomedicines10051051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10051051</ArticleId><ArticleId IdType="pmc">PMC9138404</ArticleId><ArticleId IdType="pubmed">35625788</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Padilla I., Rivera Fern&#xe1;ndez D.E., Ch&#xe1;zaro Rocha E.F., Eugenio Guti&#xe9;rrez A.L., J&#xe1;uregui-Renaud K. Body Weight May Have a Role on Neuropathy and Mobility after Moderate to Severe COVID-19: An Exploratory Study. Medicina. 2022;58:1401. doi: 10.3390/medicina58101401.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101401</ArticleId><ArticleId IdType="pmc">PMC9610119</ArticleId><ArticleId IdType="pubmed">36295562</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Navarro-Santana M., Plaza-Manzano G., Palacios-Ce&#xf1;a D., Arendt-Nielsen L. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: A systematic review and meta-analysis. Pain. 2022;163:1220&#x2013;1231. doi: 10.1097/j.pain.0000000000002496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F., G&#xfc;neri F.D., Karde&#x15f; S. Long COVID: Rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin. Rheumatol. 2022;41:289&#x2013;296. doi: 10.1007/s10067-021-05942-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05942-x</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Maamar M., Artime A., Pariente E., Fierro P., Ruiz Y., Guti&#xe9;rrez S., Tobalina M., D&#xed;az-Salazar S., Ramos C., Olmos J.M., et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: A cross-sectional study. Curr. Med. Res. Opin. 2022;38:901&#x2013;909. doi: 10.1080/03007995.2022.2042991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2042991</ArticleId><ArticleId IdType="pmc">PMC8935459</ArticleId><ArticleId IdType="pubmed">35166141</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanthanna H., Nelson A.M., Kissoon N., Narouze S. The COVID-19 pandemic and its consequences for chronic pain: A narrative review. Anaesthesia. 2022;77:1039&#x2013;1050. doi: 10.1111/anae.15801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15801</ArticleId><ArticleId IdType="pmc">PMC9350079</ArticleId><ArticleId IdType="pubmed">35848380</ArticleId></ArticleIdList></Reference><Reference><Citation>Azadvari M., Haghparast A., Nakhostin-Ansari A., Emami Razavi S.Z., Hosseini M. Musculoskeletal symptoms in patients with long COVID: A cross-sectional study on Iranian patients. Heliyon. 2022;8:e10148. doi: 10.1016/j.heliyon.2022.e10148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2022.e10148</ArticleId><ArticleId IdType="pmc">PMC9367176</ArticleId><ArticleId IdType="pubmed">35971463</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzo V., Zazzara M.B., Ciciarello F., Tosato M., Martone A.M., Pais C., Savera G., Calvani R., Picca A., Marzetti E., et al. Inadequate Physical Activity Is Associated with Worse Physical Function in a Sample of COVID-19 Survivors with Post-Acute Symptoms. J. Clin. Med. 2023;12:2517. doi: 10.3390/jcm12072517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12072517</ArticleId><ArticleId IdType="pmc">PMC10095156</ArticleId><ArticleId IdType="pubmed">37048602</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero J.I., Barrag&#xe1;n L.A., Mart&#xed;nez J.D., Montoya J.P., Pe&#xf1;a A., Sobrino F.E., Tovar-Spinoza Z., Ghotme K.A. Central and peripheral nervous system involvement by COVID-19: A systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect. Dis. 2021;21:515. doi: 10.1186/s12879-021-06185-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06185-6</ArticleId><ArticleId IdType="pmc">PMC8170436</ArticleId><ArticleId IdType="pubmed">34078305</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayaramani C., De Leon J., Reiss A.B. Cardiovascular Disease Complicating COVID-19 in the Elderly. Medicina. 2021;57:833. doi: 10.3390/medicina57080833.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57080833</ArticleId><ArticleId IdType="pmc">PMC8399122</ArticleId><ArticleId IdType="pubmed">34441038</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N., Di Napoli M., Biller J., Siegler J.E., Shekhar R., McCullough L.D., Harkins M.S., Hong E., Alaouieh D.A., Mansueto G., et al. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 2021;21:44. doi: 10.1007/s11910-021-01130-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Taga A., Lauria G. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era. J. Peripher. Nerv. Syst. 2022;27:4&#x2013;30. doi: 10.1111/jns.12482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12482</ArticleId><ArticleId IdType="pmc">PMC9115278</ArticleId><ArticleId IdType="pubmed">35137496</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaelson N.M., Malhotra A., Wang Z., Heier L., Tanji K., Wolfe S., Gupta A., MacGowan D. Peripheral neurological complications during COVID-19: A single center experience. J. Neurol. Sci. 2022;434:120118. doi: 10.1016/j.jns.2021.120118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.120118</ArticleId><ArticleId IdType="pmc">PMC8697415</ArticleId><ArticleId IdType="pubmed">34971857</ArticleId></ArticleIdList></Reference><Reference><Citation>Saif A., Pick A. Polyneuropathy following COVID-19 infection: The rehabilitation approach. BMJ Case Rep. 2021;14:e242330. doi: 10.1136/bcr-2021-242330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-242330</ArticleId><ArticleId IdType="pmc">PMC8154987</ArticleId><ArticleId IdType="pubmed">34031091</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahboubi Mehrabani M., Karvandi M.S., Maafi P., Doroudian M. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Rev. Med. Virol. 2022;32:e2334. doi: 10.1002/rmv.2334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2334</ArticleId><ArticleId IdType="pmc">PMC9111040</ArticleId><ArticleId IdType="pubmed">35138001</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung T.J., Neumann C., Bahmer T., Chaplinskaya-Sobol I., Endres M., Geritz J., Haeusler K.G., Heuschmann P.U., Hildesheim H., Hinz A., et al. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study. EClinicalMedicine. 2022;53:101651. doi: 10.1016/j.eclinm.2022.101651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101651</ArticleId><ArticleId IdType="pmc">PMC9482331</ArticleId><ArticleId IdType="pubmed">36133318</ArticleId></ArticleIdList></Reference><Reference><Citation>Albu S., Zozaya N.R., Murillo N., Garc&#xed;a-Molina A., Chac&#xf3;n C.A.F., Kumru H. Multidisciplinary outpatient rehabilitation of physical and neurological sequelae and persistent symptoms of covid-19: A prospective, observational cohort study. Disabil. Rehabil. 2022;44:6833&#x2013;6840. doi: 10.1080/09638288.2021.1977398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2021.1977398</ArticleId><ArticleId IdType="pubmed">34559592</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch J.B., Rengasamy E.R., Watson C., Jansen K., Chakraborty S., Sundaram R.D., Hafeez D., Burchill E., Saini A., Thomas L., et al. Persistent neuropsychiatric symptoms after COVID-19: A systematic review and meta-analysis. Brain Commun. 2021;4:fcab297. doi: 10.1093/braincomms/fcab297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C., Valles-Salgado M., Delgado-&#xc1;lvarez A., Yus M., G&#xf3;mez-Ruiz N., Jorquera M., Polidura C., Gil M.J., Marcos A., Mat&#xed;as-Guiu J., et al. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. J. Psychiatr. Res. 2022;150:40&#x2013;46. doi: 10.1016/j.jpsychires.2022.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoyo-Mora M., Villase&#xf1;or-Mora C., Cardona-Torres L.M., Mart&#xed;nez-Nolasco J.J., Barranco-Guti&#xe9;rrez A.I., Padilla-Medina J.A., Bravo-S&#xe1;nchez M.G. COVID-19 Long-Term Effects: Is There an Impact on the Simple Reaction Time and Alternative-Forced Choice on Recovered Patients? Brain Sci. 2022;12:1258. doi: 10.3390/brainsci12091258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12091258</ArticleId><ArticleId IdType="pmc">PMC9496861</ArticleId><ArticleId IdType="pubmed">36138994</ArticleId></ArticleIdList></Reference><Reference><Citation>Llana T., Zorzo C., Mendez-Lopez M., Mendez M. Memory alterations after COVID-19 infection: A systematic review. Appl. Neuropsychol. Adult. 2022 doi: 10.1080/23279095.2022.2123739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23279095.2022.2123739</ArticleId><ArticleId IdType="pubmed">36108666</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Samranvedhya J., Lipsitch M., Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2021;373:n1098. doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild C.J., Norton L., Menon D.K., Ripsman D.A., Swartz R.H., Owen A.M. Disentangling the cognitive, physical, and mental health sequelae of COVID-19. Cell Rep. Med. 2022;3:100750. doi: 10.1016/j.xcrm.2022.100750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100750</ArticleId><ArticleId IdType="pmc">PMC9448696</ArticleId><ArticleId IdType="pubmed">36103880</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings G., Monaghan A., Xue F., Duggan E., Romero-Ortu&#xf1;o R. Comprehensive clinical characterisation of brain fog in adults reporting long covid symptoms. J. Clin. Med. 2022;11:3440. doi: 10.3390/jcm11123440.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11123440</ArticleId><ArticleId IdType="pmc">PMC9224578</ArticleId><ArticleId IdType="pubmed">35743516</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Long Covid syndrome-associated brain fog. J. Med. Virol. 2021;94:979&#x2013;984. doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., Harrison P.J. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: An analysis of 2-year retrospective cohort studies including 1,284,437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Moy F.M., Hairi N.N., Lim E., Bulgiba A. Long COVID and its associated factors among COVID survivors in the community from a middle-income country-An online cross-sectional study. PLoS ONE. 2022;17:e0273364. doi: 10.1371/journal.pone.0273364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0273364</ArticleId><ArticleId IdType="pmc">PMC9426885</ArticleId><ArticleId IdType="pubmed">36040960</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan K., Lin Y.F., Prewitt K.-R.M., Potter D.A. Multidisciplinary approach to brain fog and related persisting symptoms post covid-19. J. Health Serv. Psychol. 2022;48:31&#x2013;38. doi: 10.1007/s42843-022-00056-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42843-022-00056-7</ArticleId><ArticleId IdType="pmc">PMC8809226</ArticleId><ArticleId IdType="pubmed">35128461</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside D.M., Basso M.R., Naini S.M., Porter J., Holker E., Waldron E.J., Melnik T.E., Niskanen N., Taylor S.E. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning. Clin. Neuropsychol. 2022;36:806&#x2013;828. doi: 10.1080/13854046.2022.2030412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2022.2030412</ArticleId><ArticleId IdType="pubmed">35130818</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristillo V., Pilotto A., Piccinelli S.C., Gipponi S., Leonardi M., Bezzi M., Padovani A. Predictors of &#x201c;brain fog&#x201d; 1 year after COVID-19 disease. Neurol. Sci. 2022;43:5795&#x2013;5797. doi: 10.1007/s10072-022-06285-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06285-4</ArticleId><ArticleId IdType="pmc">PMC9361921</ArticleId><ArticleId IdType="pubmed">35930181</ArticleId></ArticleIdList></Reference><Reference><Citation>Taube M. Depression and brain fog as long-COVID mental health consequences: Difficult, complex and partially successful treatment of a 72-year-old patient-A case report. Front. Psychiatry. 2023;14:1153512. doi: 10.3389/fpsyt.2023.1153512.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2023.1153512</ArticleId><ArticleId IdType="pmc">PMC10079873</ArticleId><ArticleId IdType="pubmed">37032935</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J. Long-COVID: Cognitive deficits (brain fog) and brain lesions in non-hospitalized patients. Presse Med. 2022;51:104090. doi: 10.1016/j.lpm.2021.104090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2021.104090</ArticleId><ArticleId IdType="pmc">PMC8552626</ArticleId><ArticleId IdType="pubmed">34718113</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao J., Frankland P.W. Covid Fog Demystified. Cell. 2022;185:2391&#x2013;2393. doi: 10.1016/j.cell.2022.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.020</ArticleId><ArticleId IdType="pmc">PMC9197953</ArticleId><ArticleId IdType="pubmed">35768007</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuber-Champier A., Cionca A., Breville G., Voruz P., de Alc&#xe2;ntara I.J., Allali G., Lalive P.H., Benzakour L., L&#xf6;vblad K.O., Braillard O., et al. Acute TNF&#x3b1; levels predict cognitive impairment 6-9 months after COVID-19 infection. Psychoneuroendocrinology. 2023;153:106104. doi: 10.1016/j.psyneuen.2023.106104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2023.106104</ArticleId><ArticleId IdType="pmc">PMC10066791</ArticleId><ArticleId IdType="pubmed">37104966</ArticleId></ArticleIdList></Reference><Reference><Citation>He D., Yuan M., Dang W., Bai L., Yang R., Wang J., Ma Y., Liu B., Liu S., Zhang S., et al. Long term neuropsychiatric consequences in COVID-19 survivors: Cognitive impairment and inflammatory underpinnings fifteen months after discharge. Asian J. Psychiatr. 2023;80:103409. doi: 10.1016/j.ajp.2022.103409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2022.103409</ArticleId><ArticleId IdType="pmc">PMC9751007</ArticleId><ArticleId IdType="pubmed">36549172</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. COVID and the brain: Researchers zero in on how damage occurs. Nature. 2021;595:484&#x2013;485. doi: 10.1038/d41586-021-01693-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01693-6</ArticleId><ArticleId IdType="pubmed">34234323</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon C.L., Staples H., Gazi M., Carrion R., Hsieh J. SARS-CoV-2 targets glial cells in human cortical organoids. Stem Cell Rep. 2021;16:1156&#x2013;1164. doi: 10.1016/j.stemcr.2021.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.01.016</ArticleId><ArticleId IdType="pmc">PMC8111796</ArticleId><ArticleId IdType="pubmed">33979600</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein Ferber S., Shoval G., Zalsman G., Weller A. Does COVID-19 related symptomatology indicate a transdiagnostic neuropsychiatric disorder?&#x2014;Multidisciplinary implications. World J. Psychiatry. 2022;12:1004&#x2013;1015. doi: 10.5498/wjp.v12.i8.1004.</Citation><ArticleIdList><ArticleId IdType="doi">10.5498/wjp.v12.i8.1004</ArticleId><ArticleId IdType="pmc">PMC9476837</ArticleId><ArticleId IdType="pubmed">36158308</ArticleId></ArticleIdList></Reference><Reference><Citation>Trecca E.M.C., Cassano M., Longo F., Petrone P., Miani C., Hummel T., Gelardi M. Results from psychophysical tests of smell and taste during the course of SARS-CoV-2 infection: A review. Acta Otorhinolaryngol. Ital. 2022;42:S20&#x2013;S35. doi: 10.14639/0392-100X-suppl.1-42-2022-03.</Citation><ArticleIdList><ArticleId IdType="doi">10.14639/0392-100X-suppl.1-42-2022-03</ArticleId><ArticleId IdType="pmc">PMC9137382</ArticleId><ArticleId IdType="pubmed">35763272</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa Dos Santos J., Ximenes Rabelo M., Mattana Sebben L., de Souza Carneiro M.V., Bosco Lopes Botelho J., Cardoso Neto J., Nogueira Barbosa A., Monteiro de Carvalho D., Pontes G.S. Persistence of SARS-CoV-2 Antigens in the Nasal Mucosa of Eight Patients with Inflammatory Rhinopathy for over 80 Days following Mild COVID-19 Diagnosis. Viruses. 2023;15:899. doi: 10.3390/v15040899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040899</ArticleId><ArticleId IdType="pmc">PMC10143909</ArticleId><ArticleId IdType="pubmed">37112879</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya H. Oral Symptoms Associated with COVID-19 and Their Pathogenic Mechanisms: A Literature Review. Dent. J. 2021;9:32. doi: 10.3390/dj9030032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/dj9030032</ArticleId><ArticleId IdType="pmc">PMC7999671</ArticleId><ArticleId IdType="pubmed">33799583</ArticleId></ArticleIdList></Reference><Reference><Citation>Han A.Y., Mukdad L., Long J.L., Lopez I.A. Anosmia in COVID-19: Mechanisms and significance. Chem. Senses. 2020;45:423&#x2013;428. doi: 10.1093/chemse/bjaa040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjaa040</ArticleId><ArticleId IdType="pmc">PMC7449368</ArticleId><ArticleId IdType="pubmed">32556089</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott M., Driscoll R., Pardhan S. The prevalence of sensory changes in post-COVID syndrome: A systematic review and meta-analysis. Front. Med. 2022;9:980253. doi: 10.3389/fmed.2022.980253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.980253</ArticleId><ArticleId IdType="pmc">PMC9452774</ArticleId><ArticleId IdType="pubmed">36091707</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M., Babicki M., Mastalerz-Migas A., Kapusta J. Persisting Smell and Taste Disorders in Patients Who Recovered from SARS-CoV-2 Virus Infection-Data from the Polish PoLoCOV-CVD Study. Viruses. 2022;14:1763. doi: 10.3390/v14081763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081763</ArticleId><ArticleId IdType="pmc">PMC9416276</ArticleId><ArticleId IdType="pubmed">36016385</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B.K.J., Han R., Zhao J.J., Tan N.K.W., Quah E.S.H., Tan C.J., Chan Y.H., Teo N.W.Y., Charn T.C., See A., et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: Meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. doi: 10.1136/bmj-2021-069503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069503</ArticleId><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmsdal G., Hanusson K.D., Kristiansen M.F., Foldbo B.M., Danielsen M.E., Steig B.&#xc1;., Gaini S., Str&#xf8;m M., Weihe P., Petersen M.S. Long COVID in the Long Run-23-Month Follow-up Study of Persistent Symptoms. Open Forum Infect. Dis. 2022;9:ofac270. doi: 10.1093/ofid/ofac270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac270</ArticleId><ArticleId IdType="pmc">PMC9308378</ArticleId><ArticleId IdType="pubmed">35891696</ArticleId></ArticleIdList></Reference><Reference><Citation>Prem B., Liu D.T., Besser G., Sharma G., Dultinger L.E., Hofer S.V., Matiasczyk M.M., Renner B., Mueller C.A. Long-lasting olfactory dysfunction in COVID-19 patients. Eur. Arch. Otorhinolaryngol. 2021;279:3485&#x2013;3492. doi: 10.1007/s00405-021-07153-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-07153-1</ArticleId><ArticleId IdType="pmc">PMC8578909</ArticleId><ArticleId IdType="pubmed">34757458</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Tofanelli M., Zanelli E., Gardenal N., Tirelli G. COVID-19-Related Quantitative and Qualitative Olfactory and Gustatory Dysfunction: Long-Term Prevalence and Recovery Rate. ORL J. Otorhinolaryngol. Relat. Spec. 2023;85:67&#x2013;71. doi: 10.1159/000525861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000525861</ArticleId><ArticleId IdType="pmc">PMC9747726</ArticleId><ArticleId IdType="pubmed">36063810</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid R.A., Alaqeedy A.A., Al-Ani R.M. Parosmia Due to COVID-19 Disease: A 268 Case Series. Indian J. Otolaryngol. Head Neck Surg. 2022;74:2970&#x2013;2977. doi: 10.1007/s12070-021-02630-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-021-02630-9</ArticleId><ArticleId IdType="pmc">PMC8141364</ArticleId><ArticleId IdType="pubmed">34055592</ArticleId></ArticleIdList></Reference><Reference><Citation>Melley L.E., Bress E., Polan E. Hypogeusia as the initial presenting symptom of COVID-19. BMJ Case Rep. 2020;13:e236080. doi: 10.1136/bcr-2020-236080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-236080</ArticleId><ArticleId IdType="pmc">PMC7228456</ArticleId><ArticleId IdType="pubmed">32404376</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuter G., Yerebakan M., Celik B., Kara G. Oral manifestations in SARS-CoV-2 infection. Med. Oral Patol. Oral Cir. Bucal. 2022;27:e330&#x2013;e339. doi: 10.4317/medoral.25259.</Citation><ArticleIdList><ArticleId IdType="doi">10.4317/medoral.25259</ArticleId><ArticleId IdType="pmc">PMC9271340</ArticleId><ArticleId IdType="pubmed">35717616</ArticleId></ArticleIdList></Reference><Reference><Citation>Park G.C., Bang S.Y., Lee H.W., Choi K.U., Kim J.M., Shin S.C., Cheon Y.I., Sung E.S., Lee M., Lee J.C., et al. ACE2 and TMPRSS2 immunolocalization and oral manifestations of COVID-19. Oral Dis. 2022;28:2456&#x2013;2464. doi: 10.1111/odi.14126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.14126</ArticleId><ArticleId IdType="pubmed">35000261</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandersteen C., Payne M., Dumas L.&#xc9;., Cancian &#xc9;., Plonka A., D&#x2019;Andr&#xe9;a G., Chirio D., Demonchy &#xc9;., Risso K., Askenazy-Gittard F., et al. Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification. J. Clin. Med. 2022;11:3275. doi: 10.3390/jcm11123275.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11123275</ArticleId><ArticleId IdType="pmc">PMC9224948</ArticleId><ArticleId IdType="pubmed">35743346</ArticleId></ArticleIdList></Reference><Reference><Citation>Donelli D., Antonelli M., Valussi M. Olfactory training with essential oils for patients with post-COVID-19 smell dysfunction: A case series. Eur. J. Integr. Med. 2023;60:102253. doi: 10.1016/j.eujim.2023.102253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eujim.2023.102253</ArticleId><ArticleId IdType="pmc">PMC10102705</ArticleId><ArticleId IdType="pubmed">37163157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig S., Schell A., Berkemann M., Jungbauer F., Zaubitzer L., Huber L., Warken C., Held V., Kusnik A., Teufel A., et al. Post-COVID-19 Impairment of the Senses of Smell, Taste, Hearing, and Balance. Viruses. 2022;14:849. doi: 10.3390/v14050849.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14050849</ArticleId><ArticleId IdType="pmc">PMC9145380</ArticleId><ArticleId IdType="pubmed">35632590</ArticleId></ArticleIdList></Reference><Reference><Citation>Degen C.V., Mikuteit M., Niewolik J., Joosten T., Schr&#xf6;der D., Vahldiek K., M&#xfc;cke U., Heinemann S., M&#xfc;ller F., Behrens G.M.N., et al. Audiological profile of adult Long COVID patients. Am. J. Otolaryngol. 2022;43:103579. doi: 10.1016/j.amjoto.2022.103579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2022.103579</ArticleId><ArticleId IdType="pmc">PMC9354445</ArticleId><ArticleId IdType="pubmed">35988361</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca P., Di Stadio A., Colacurcio V., Marra P., Scarpa A., Ricciardiello F., Cassandro C., Camaioni A., Cassandro E. COVID, audiovestibular symptoms and persistent chemosensory dysfunction: A systematic review of the current evidence. Acta Otorhinolaryngol. Ital. 2022;42:S87&#x2013;S93. doi: 10.14639/0392-100X-suppl.1-42-2022-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.14639/0392-100X-suppl.1-42-2022-10</ArticleId><ArticleId IdType="pmc">PMC9137376</ArticleId><ArticleId IdType="pubmed">35763279</ArticleId></ArticleIdList></Reference><Reference><Citation>McFadyen J.D., Stevens H., Peter K. The emerging threat of (micro)thrombosis in COVID-19 and Its therapeutic implications. Circ. Res. 2020;127:571&#x2013;587. doi: 10.1161/CIRCRESAHA.120.317447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317447</ArticleId><ArticleId IdType="pmc">PMC7386875</ArticleId><ArticleId IdType="pubmed">32586214</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorobisz K., Pazdro-Zastawny K., Misiak P., Kruk-Krzemie&#x144; A., Zato&#x144;ski T. Sensorineural Hearing Loss in Patients with Long-COVID-19: Objective and Behavioral Audiometric Findings. Infect. Drug Resist. 2023;16:1931&#x2013;1939. doi: 10.2147/IDR.S398126.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S398126</ArticleId><ArticleId IdType="pmc">PMC10072149</ArticleId><ArticleId IdType="pubmed">37025195</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho D.H., Reiter E.R., French E., Costanzo R.M. Decreasing Incidence of Chemosensory Changes by COVID-19 Variant. Otolaryngol. Head Neck Surg. 2023;168:704&#x2013;706. doi: 10.1177/01945998221097656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01945998221097656</ArticleId><ArticleId IdType="pmc">PMC9630171</ArticleId><ArticleId IdType="pubmed">35503739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazhytska M., Kodra A., Hoagland D.A., Frere J., Fullard J.F., Shayya H., McArthur N.G., Moeller R., Uhl S., Omer A.D., et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell. 2022;185:1052&#x2013;1064. doi: 10.1016/j.cell.2022.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.024</ArticleId><ArticleId IdType="pmc">PMC8808699</ArticleId><ArticleId IdType="pubmed">35180380</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyaolu A., Marinkovic A., Prakash S., Zhao A., Balendra V., Haider N., Jain I., Simic T., Okorie C. Post-acute Sequelae in COVID-19 Survivors: An Overview. SN Compr. Clin. Med. 2022;4:91. doi: 10.1007/s42399-022-01172-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01172-7</ArticleId><ArticleId IdType="pmc">PMC8985741</ArticleId><ArticleId IdType="pubmed">35411333</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;nc&#xfc;l H., &#xd6;nc&#xfc;l F.Y., Alakus M.F., &#xc7;a&#x11f;layan M., Dag U. Ocular findings in patients with coronavirus disease 2019 (COVID-19) in an outbreak hospital. J. Med. Virol. 2020;93:1126&#x2013;1132. doi: 10.1002/jmv.26412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26412</ArticleId><ArticleId IdType="pmc">PMC7436579</ArticleId><ArticleId IdType="pubmed">32776614</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohamy D., Sharaf M., Abdelazeem K., Saleh M.G.A., Rateb M.F., Soliman W., Kedwany S.M., Omar Abdelmalek M., Medhat M.A., Tohamy A.M., et al. Ocular manifestations of post-acute covid-19 syndrome, Upper Egypt Early Report. J. Multidiscip. Healthc. 2021;14:1935&#x2013;1944. doi: 10.2147/JMDH.S323582.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S323582</ArticleId><ArticleId IdType="pmc">PMC8315779</ArticleId><ArticleId IdType="pubmed">34326644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazantzis D., Machairoudia G., Theodossiadis G., Theodossiadis P., Chatziralli I. Retinal microvascular changes in patients recovered from COVID-19 compared to healthy controls: A meta-analysis. Photodiagnosis Photodyn. Ther. 2023;42:103556. doi: 10.1016/j.pdpdt.2023.103556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2023.103556</ArticleId><ArticleId IdType="pmc">PMC10072975</ArticleId><ArticleId IdType="pubmed">37023998</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevnikar K., Megli&#x10d; A., Lapajne L., Logar M., Vidovi&#x10d; Valentin&#x10d;i&#x10d; N., Globo&#x10d;nik Petrovi&#x10d; M., Jaki Mekjavi&#x107; P. The Comparison of Retinal Microvascular Findings in Acute COVID-19 and 1-Year after Hospital Discharge Assessed with Multimodal Imaging-A Prospective Longitudinal Cohort Study. Int. J. Mol. Sci. 2023;24:4032. doi: 10.3390/ijms24044032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24044032</ArticleId><ArticleId IdType="pmc">PMC9966689</ArticleId><ArticleId IdType="pubmed">36835445</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson J., M&#xf6;ller M., Markovic G., Borg K. Vision impairment is common in non-hospitalised patients with post-COVID-19 syndrome. Clin. Exp. Optom. 2023. Advance online publication .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08164622.2023.2213826</ArticleId><ArticleId IdType="pubmed">37201931</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>